Corbion stock trades near its yearly high as margins reset

Published on 09/28/2026 at 15:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Corbion stock carries a EUR 26.00 ABN AMRO target dated September 10, 2026. H1 sales were EUR 631.1 million and Q2 organic growth reached 8.5 percent.

Isometrische 3D-Grafik von Rohstoffen, Fermentationstanks und verpackten Ingredienzien — Isometrische 3D-Illustration der Wertschöpfungskette veranschaulicht den Produktionsprozess von Corbion N.V. (ISIN NL0010583399), Illustration mit AI erstellt.

Corbion stock (ISIN NL0010583399) was trading at EUR 22.56 on Euronext Amsterdam on September 28, 2026, up 0.71 percent from EUR 22.40. The price stood 2.51 percent below the 52-week high of EUR 23.14, giving investors a clear market measure alongside the company’s improving second-quarter momentum.

Analyst target moves to EUR 26.00

ABN AMRO raised its Corbion price target from EUR 23.00 to EUR 26.00 on September 10, 2026, while keeping its Outperform rating, according to MarketScreener. The target is EUR 3.44 above the September 28 trading price, or 15.25 percent higher, although that comparison is an analyst view rather than a company forecast.

The bank linked its upgrade to higher estimates for adjusted EBITDA in 2027 and 2028, which it raised by 6 percent and 8 percent. Its adjusted EBITDA margin estimates were 16.00 percent for 2026, 17.40 percent for 2027 and 18.20 percent for 2028.

Q2 growth offsets a softer half

Corbion’s July 31, 2026 results release reported Q2 organic sales growth of 8.50 percent to EUR 337.40 million and adjusted EBITDA of EUR 51.00 million, as shown on the company’s investor relations page. For the first half, sales were EUR 631.10 million, compared with EUR 645.60 million in H1 2025, while adjusted EBITDA was EUR 88.80 million versus EUR 106.60 million.

The H1 figures show the tension in the investment case: Q2 organic sales growth accelerated to 8.50 percent, but first-half adjusted EBITDA declined 16.70 percent year over year. The earnings-call transcript also noted a 220-basis-point sequential improvement in the adjusted EBITDA margin in Q2, according to Yahoo Finance.

Guidance stays cautious

Management maintained its 2026 organic sales growth outlook of 3 percent to 6 percent and free cash flow guidance of EUR 85 million to EUR 90 million. It refined the adjusted EBITDA margin outlook to above 16 percent from a previous indication of 17 percent, keeping margin delivery and cash conversion central to the next results update.

Stock remains below its yearly high

Corbion stock was last trading at EUR 22.56 on Euronext Amsterdam on September 28, 2026, with volume of 35,823 shares and market capitalization of EUR 1.3 billion. The next results publication is scheduled for October 28, 2026.